1
|
He Y, Xu Y, Lin Z. Association between alcohol consumption and allergic rhinitis in US adults. Front Nutr 2025; 12:1544889. [PMID: 40191794 PMCID: PMC11968348 DOI: 10.3389/fnut.2025.1544889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2024] [Accepted: 03/06/2025] [Indexed: 04/09/2025] Open
Abstract
Introduction Increasing evidence suggests that alcohol consumption may be associated with allergic diseases. This cross-sectional analysis aimed to determine the correlation between alcohol consumption patterns and allergic rhinitis (AR) in US adults. Methods A cross-sectional study was conducted involving 2,179 individuals aged 20 years and older who took part in the 2005-2006 National Health and Nutrition Examination Survey (NHANES), which assessed AR and alcohol consumption patterns. Alcohol consumption was categorized into three groups: "Never" (fewer than 12 drinks in a lifetime), "Now" (currently drinking), and "Former" (a prior history of drinking but no longer consuming alcohol). The association between alcohol consumption patterns and AR was analyzed separately for men and women, adjusting for several comorbidities. Results Individuals who currently consume alcohol are more likely to exhibit elevated levels of total IgE and cat/dog dander-specific IgE compared to non-consumers. Compared to "Never" in the male group, "Now" (currently drinking) was positively associated with AR in both the partially adjusted analysis and the fully adjusted model. However, we did not find any positive relationship between alcohol consumption patterns and AR in the female group, which suggests that current drinking was linked to a higher prevalence of AR in men but not in women. Conclusion We discovered that current drinking was positively associated with a high prevalence of AR in men.
Collapse
Affiliation(s)
- Yan He
- Department of Otolaryngology Head and Neck Surgery, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Gusu School Nanjing Medical University, Suzhou, China
| | - Yingying Xu
- Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Jiangxi Medical College, Nanchang University, Nanchang, China
| | - Zhiqiang Lin
- Department of Otolaryngology Head and Neck Surgery, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Gusu School Nanjing Medical University, Suzhou, China
| |
Collapse
|
2
|
Ruzante JM, Rains C, Viator C, Liao D, Creel D, Luccioli S, Anic G, Wolpert BJ, Warren C, DiGrande L. The Current State of Data to Estimate Prevalence and Severity of Food Allergies in the United States. J Food Prot 2025; 88:100424. [PMID: 39631453 DOI: 10.1016/j.jfp.2024.100424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2024] [Revised: 11/22/2024] [Accepted: 11/25/2024] [Indexed: 12/07/2024]
Abstract
Currently, in the United States, there is no comprehensive surveillance system to collect data on food allergies; however, prevalence and severity data are critical to quantify the burden of food allergies, develop evidence-based control measures, detect emerging issues, and monitor trends. To address this gap, we conducted a literature search, and expert interviews to identify surveillance systems and datasets that could be used to estimate the prevalence and severity of food allergies in the United States overall and for specific foods. Inclusion and exclusion criteria were developed and used to screen each data source. Selected articles were evaluated according to quality parameters to identify the most appropriate studies. Most studies estimated the prevalence of food allergies in children, investigated multiple foods, and used surveys to collect self-reported data. Despite the high quality, robust study designs, and comprehensive survey instruments that currently exist, the studies identified do not provide sufficiently recent data to estimate the current burden of food allergies in the country. Studies lack consistencies across the years making the analysis of trends over time a challenge. National surveys conducted by Northwestern University in 2009/2010 and 2015/2016 represented the best available data; however, these data are likely outdated and are limited in assessing temporal food allergy trends. Data to accurately estimate the current prevalence and severity of food allergies and related trends are lacking. U.S. public health agencies should explore the development of a comprehensive surveillance program to address this gap and help inform evidence-based policies in food allergy management and prevention.
Collapse
Affiliation(s)
- Juliana M Ruzante
- RTI International, 3040 E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709-2194, United States.
| | - Caroline Rains
- RTI International, 3040 E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709-2194, United States
| | - Catherine Viator
- RTI International, 3040 E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709-2194, United States
| | - Dan Liao
- RTI International, 3040 E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709-2194, United States
| | - Darryl Creel
- RTI International, 3040 E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709-2194, United States
| | - Stefano Luccioli
- Human Foods Program, Food and Drug Administration, 5001 Campus Drive, College Park, MD 20740, United States
| | - Gabriella Anic
- Human Foods Program, Food and Drug Administration, 5001 Campus Drive, College Park, MD 20740, United States
| | - Beverly J Wolpert
- Human Foods Program, Food and Drug Administration, 5001 Campus Drive, College Park, MD 20740, United States
| | - Christopher Warren
- Northwestern University's Center for Food Allergy and Asthma Research (CFAAR), 750 N. Lake Shore Dr., Chicago, IL 60611, United States
| | - Laura DiGrande
- RTI International, 3040 E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709-2194, United States
| |
Collapse
|
3
|
Bégin P, Waserman S, Protudjer JLP, Jeimy S, Watson W. Immunoglobulin E (IgE)-mediated food allergy. ALLERGY, ASTHMA, AND CLINICAL IMMUNOLOGY : OFFICIAL JOURNAL OF THE CANADIAN SOCIETY OF ALLERGY AND CLINICAL IMMUNOLOGY 2024; 20:75. [PMID: 39736801 PMCID: PMC11684040 DOI: 10.1186/s13223-024-00930-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/26/2024] [Accepted: 11/15/2024] [Indexed: 01/01/2025]
Abstract
Food allergy is defined as an adverse immunologic response to a food. Immunoglobulin E (IgE)-mediated reactions to foods are associated with a broad range of signs and symptoms that may involve any of the following body systems: the skin, gastrointestinal tract, respiratory tract, and cardiovascular system. IgE-mediated food allergy is a leading cause of anaphylaxis. Therefore, timely and appropriate diagnosis and treatment are imperative. A diagnosis of food allergy entails a careful history and diagnostic tests, which may include skin prick tests, serum-specific IgE, and oral food challenge. The goal of food allergy care is to empower patients and caregivers to manage the risk of food-allergic reactions, reduce food allergy-related anxiety, and achieve a sense of control over their condition. This can be achieved in different ways for different patients and across different life stages. This article provides an overview of the epidemiology, pathophysiology, diagnosis, and management of IgE-mediated food allergy.
Collapse
Affiliation(s)
- Philippe Bégin
- Division of Clinical Immunology and Allergy, Department of Medicine, Université de Montréal, Montréal, Québec, Canada.
| | - Susan Waserman
- Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, Canada
| | - Jennifer L P Protudjer
- Department of Pediatrics and Child Health, College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
- Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada
| | - Samira Jeimy
- Division of Clinical Immunology and Allergy, Department of Medicine, Western University, London, ON, Canada
| | - Wade Watson
- Division of Allergy, Department of Pediatrics, Dalhousie University, IWK Health Centre, Halifax, NS, Canada
| |
Collapse
|
4
|
Abrams EM, Alqurashi W, Fischer DA, Vander Leek TK, Ellis AK. Anaphylaxis. ALLERGY, ASTHMA, AND CLINICAL IMMUNOLOGY : OFFICIAL JOURNAL OF THE CANADIAN SOCIETY OF ALLERGY AND CLINICAL IMMUNOLOGY 2024; 20:62. [PMID: 39654057 PMCID: PMC11629490 DOI: 10.1186/s13223-024-00926-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/12/2024] [Accepted: 11/13/2024] [Indexed: 12/12/2024]
Abstract
Anaphylaxis is an acute, potentially fatal systemic hypersensitivity reaction with varied mechanisms and clinical presentations. Although prompt recognition and treatment of anaphylaxis are imperative, both patients and healthcare professionals often fail to recognize and diagnose its early signs. Clinical manifestations vary widely, however, the most common signs are cutaneous symptoms, including urticaria and angioedema. Immediate intramuscular administration of epinephrine into the anterolateral thigh is first-line therapy, and is always safe even if the diagnosis is uncertain. The mainstays of long-term management include specialist assessment, allergen avoidance measures, and the provision of an epinephrine auto-injector with an individualized anaphylaxis emergency plan. This article provides an overview of the causes, clinical features, diagnosis, and acute as well as long-term management of anaphylaxis.
Collapse
Affiliation(s)
- Elissa M Abrams
- Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.
- Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, MB, Canada.
| | - Waleed Alqurashi
- Department of Pediatrics and Emergency Medicine, University of Ottawa, Ottawa, ON, Canada
| | - David A Fischer
- Division of Allergy, Department of Internal Medicine, Western University, London, ON, Canada
| | - Timothy K Vander Leek
- Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada
| | - Anne K Ellis
- Division of Allergy & Immunology, Department of Medicine, Queen's University, Kingston, ON, Canada
| |
Collapse
|
5
|
Turner PJ, Bognanni A, Arasi S, Ansotegui IJ, Schnadt S, La Vieille S, Hourihane JO, Zuberbier T, Eigenmann P, Ebisawa M, Morais-Almeida M, Barnett J, Martin B, Monaci L, Roberts G, Wong G, Gupta R, Tsabouri S, Mills C, Brooke-Taylor S, Bartra J, Levin M, Groetch M, Tanno L, Hossny E, Weber BB, Fierro V, Remington B, Gerdts J, Gowland MH, Chu D, Van Ravenhorst M, Koplin J, Fiocchi A, World Allergy Organization Consensus on the Use of PAL (ACT-UP!) Working
Group. Time to ACT-UP: Update on precautionary allergen labelling (PAL). World Allergy Organ J 2024; 17:100972. [PMID: 39381624 PMCID: PMC11459638 DOI: 10.1016/j.waojou.2024.100972] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2024] [Revised: 08/30/2024] [Accepted: 08/30/2024] [Indexed: 10/10/2024] Open
Abstract
Background Precautionary Allergen ("may contain") Labelling (PAL) is used by industry to communicate potential risk to food-allergic individuals posed by unintended allergen presence (UAP). In 2014, the World Allergy Organization (WAO) highlighted that PAL use was increasing, but often applied inconsistently and without regulation - which reduces its usefulness to consumers with food allergy and those purchasing food for them. WAO proposed the need for a regulated, international framework to underpin application of PAL. In 2019, the World Health Organization (WHO) and the Food and Agriculture Organization (FAO) of the United Nations convened an expert consultation to address the issue of PAL, the outputs of which are now being considered by the Codex Committee on Food Labelling (CCFL). Objectives To summarise the latest data to inform the application of PAL in a more systematic way, for implementation into global food standards. Methods A non-systematic review of issues surrounding precautionary labelling and food allergens in pre-packaged products. Results Approximately, 100 countries around the world have legislation on the declaration of allergenic ingredients. Just a few have legislation on UAP. Given the risks that UAP entails, non-regulated PAL creates inconvenience in real life due to its unequal, difficult interpretation by patients. The attempts made so far to rationalize PAL present lights and shadows. Conclusions At a time when CCFL is considering the results of the FAO/WHO Expert Consultation 2020-2023, we summarise the prospects to develop an effective and homogeneous legislation at a global level, and the areas of uncertainty that might hinder international agreement on a regulated framework for PAL of food allergens.
Collapse
Affiliation(s)
- Paul J. Turner
- National Heart & Lung Institute, Imperial College London, London,
UK
| | - Antonio Bognanni
- Department of Health Research Methods, Evidence, and Impact, McMaster
University, Hamilton, ON, Canada
- Clinical Epidemiology and Research Center (CERC), Humanitas University
& Humanitas Research Hospital, Via Rita Levi Montalcini 4, 20090 Pieve
Emanuele, Milano, Italy
- Department of Medicine, Evidence in Allergy Group, McMaster University,
Hamilton, ON, Canada
| | - Stefania Arasi
- Allergy Unit, Pediatric Hospital Bambino Gesù IRCCS, Rome,
Italy
| | | | - Sabine Schnadt
- Deutscher Allergie- und Asthmabund (DAAB), Moenchengladbach D,
Germany
| | - Sébastien La Vieille
- Food Directorate, Health Canada, Ottawa, ON, Canada
- Food Science Department, Laval University, Québec, QC, Canada
| | - Jonathan O’B. Hourihane
- Paediatrics and Child Health, Royal College of Surgeons Ireland, Dublin,
Ireland
- Children's Health Ireland, Dublin, Ireland
| | | | | | | | | | | | - Bryan Martin
- Medicine and Pediatrics, The Ohio State University in Columbus, Columbus,
OH, USA
| | - Linda Monaci
- Institute of Sciences of Food Production, National Research Council
(ISPA-CNR), Bari, Italy
| | | | - Gary Wong
- The Chinese University of Hong Kong, Hong Kong, PR China
| | - Ruchi Gupta
- Northwestern University, Chicago, IL, USA
- Food Allergy Research & Education (FARE), McLean, VA, USA
| | - Sophia Tsabouri
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) and Child
Health Department, University of Ioannina School of Medicine, Ioannina,
Greece
| | | | | | - Joan Bartra
- Allergy Department, Hospital Clinic and IDIBAPS. Universitat de
Barcelona, Spain
- RICORS de Enfermedades Inflamatorias (ISCIII), Madrid, Spain
| | - Michael Levin
- Division of Paediatric Allergy, Department of Paediatrics and Child
Health, University of Cape Town, Cape Town, South Africa
| | - Marion Groetch
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | - Elham Hossny
- Pediatric Allergy, Immunology and Rheumatology Unit, Children's Hospital,
Ain Shams University, Cairo, Egypt
| | - Barbara Ballmer Weber
- Department of Dermatology, University Hospital Zürich, Zürich,
Switzerland and Clinic for Dermatology and Allergology, Kantonsspital St.
Gallen, St. Gallen, Switzerland
| | - Vincenzo Fierro
- Allergy Unit, Pediatric Hospital Bambino Gesù IRCCS, Rome,
Italy
| | - Ben Remington
- Food Allergy Research and Resource Program, Department of Food Science
and Technology, University of Nebraska, Lincoln, NE, USA
- Remington Consulting Group B.V, Utrecht, the Netherlands
| | | | | | - Derek Chu
- Department of Health Research Methods, Evidence, and Impact, McMaster
University, Hamilton, Ontario, Canada
- Department of Medicine, Evidence in Allergy Group, McMaster University,
Hamilton, Ontario, Canada
| | | | - Jennifer Koplin
- Child Health Research Centre, University of Queensland, Brisbane,
Queensland, Australia
- Centre for Food and Allergy Research, Melbourne, Victoria,
Australia
| | | | - World Allergy Organization Consensus on the Use of PAL (ACT-UP!) Working
Group
- National Heart & Lung Institute, Imperial College London, London,
UK
- Department of Health Research Methods, Evidence, and Impact, McMaster
University, Hamilton, ON, Canada
- Clinical Epidemiology and Research Center (CERC), Humanitas University
& Humanitas Research Hospital, Via Rita Levi Montalcini 4, 20090 Pieve
Emanuele, Milano, Italy
- Department of Medicine, Evidence in Allergy Group, McMaster University,
Hamilton, ON, Canada
- Allergy Unit, Pediatric Hospital Bambino Gesù IRCCS, Rome,
Italy
- Hospital Quironsalud Bizkaia, Bilbao, Spain
- Deutscher Allergie- und Asthmabund (DAAB), Moenchengladbach D,
Germany
- Food Directorate, Health Canada, Ottawa, ON, Canada
- Food Science Department, Laval University, Québec, QC, Canada
- Paediatrics and Child Health, Royal College of Surgeons Ireland, Dublin,
Ireland
- Children's Health Ireland, Dublin, Ireland
- Charite University, Berlin, Germany
- Pediatric Allergy Unit, University of Geneva, Switzerland
- Sagamihara National Hospital, Sagamihara, Japan
- Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal
- Department of Psychology, University of Bath, UK
- Medicine and Pediatrics, The Ohio State University in Columbus, Columbus,
OH, USA
- Institute of Sciences of Food Production, National Research Council
(ISPA-CNR), Bari, Italy
- University Hospital Southampton, Southampton, UK
- The Chinese University of Hong Kong, Hong Kong, PR China
- Northwestern University, Chicago, IL, USA
- Food Allergy Research & Education (FARE), McLean, VA, USA
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) and Child
Health Department, University of Ioannina School of Medicine, Ioannina,
Greece
- University of Manchester, Manchester, UK
- Brooke-Taylor & Co Pty Ltd, Milawa, Victoria, Australia
- Allergy Department, Hospital Clinic and IDIBAPS. Universitat de
Barcelona, Spain
- RICORS de Enfermedades Inflamatorias (ISCIII), Madrid, Spain
- Division of Paediatric Allergy, Department of Paediatrics and Child
Health, University of Cape Town, Cape Town, South Africa
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Sanas Epidemiology and Research, Sao Paulo, Brazil
- Pediatric Allergy, Immunology and Rheumatology Unit, Children's Hospital,
Ain Shams University, Cairo, Egypt
- Department of Dermatology, University Hospital Zürich, Zürich,
Switzerland and Clinic for Dermatology and Allergology, Kantonsspital St.
Gallen, St. Gallen, Switzerland
- Food Allergy Research and Resource Program, Department of Food Science
and Technology, University of Nebraska, Lincoln, NE, USA
- Remington Consulting Group B.V, Utrecht, the Netherlands
- Food Allergy Canada, Toronto, Ontario, Canada
- Allergy Action, St Albans, UK
- Department of Health Research Methods, Evidence, and Impact, McMaster
University, Hamilton, Ontario, Canada
- Department of Medicine, Evidence in Allergy Group, McMaster University,
Hamilton, Ontario, Canada
- Allergenen Consultancy BV, Scherpenzeel (Gld), the
Netherlands
- Child Health Research Centre, University of Queensland, Brisbane,
Queensland, Australia
- Centre for Food and Allergy Research, Melbourne, Victoria,
Australia
| |
Collapse
|
6
|
Chong T, Olivieri B, Skypala IJ. Food-triggered anaphylaxis in adults. Curr Opin Allergy Clin Immunol 2024; 24:341-348. [PMID: 39079158 DOI: 10.1097/aci.0000000000001008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2024]
Abstract
PURPOSE OF REVIEW Adult food allergy, either unresolved from childhood, or new-onset in adult-life, is known to be increasingly prevalent. Although much of the reported anaphylaxis in adults is due to drug reactions, foods are becoming an increasingly important trigger, affecting adults of all ages, with a wide variation in food triggers which are often quite different to those reported in children. RECENT FINDINGS Peanuts are well known to cause anaphylaxis in some adult populations, but other legumes such as soy may be more relevant in others. Reactions to natto, fermented soybeans, are currently mainly reported in Japan, but changing dietary practices and an increase in plant-based eating mean natto, other forms of soy and other legumes are increasingly linked to anaphylaxis in Western countries. Anaphylaxis to red meat, caused by sensitization to galactose-α-1,3-galactose and first reported in North America, is now a more world-wide concern. Co-factor induced anaphylaxis is increasingly associated with both wheat allergy and lipid transfer protein allergy. SUMMARY More research is urgently needed to characterize adult food allergy, its triggers and symptom severity. Unusual food triggers and potential co-factors should be considered, so that anaphylaxis in adults can be correctly managed, not merely labelled as idiopathic.
Collapse
Affiliation(s)
| | - Bianca Olivieri
- Department of Medicine, Asthma, Allergy and Clinical Immunology Section, University of Verona, Verona, Italy
| | - Isabel J Skypala
- Royal Brompton & Harefield Hospitals, part of Guys & St Thomas NHS Foundation Trust
- Department of Inflammation & Repair, Imperial College, London, UK
| |
Collapse
|
7
|
Jimenez-Garcia R, Lopez-de-Andres A, Hernandez-Barrera V, Zamorano-Leon JJ, Cuadrado-Corrales N, de Miguel-Diez J, Del-Barrio JL, Jimenez-Sierra A, Carabantes-Alarcon D. Hospitalizations for Food-Induced Anaphylaxis Between 2016 and 2021: Population-Based Epidemiologic Study. JMIR Public Health Surveill 2024; 10:e57340. [PMID: 38940759 PMCID: PMC11387914 DOI: 10.2196/57340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2024] [Revised: 03/21/2024] [Accepted: 05/21/2024] [Indexed: 06/29/2024] Open
Abstract
BACKGROUND Food-induced anaphylaxis (FIA) is a major public health problem resulting in serious clinical complications, emergency department visits, hospitalization, and death. OBJECTIVE This study aims to assess the epidemiology and the trends in hospitalizations because of FIA in Spain between 2016 and 2021. METHODS An observational descriptive study was conducted using data from the Spanish National Hospital discharge database. Information was coded based on the International Classification of Diseases, Tenth Revision. The study population was analyzed by gender and age group and according to food triggers, clinical characteristics, admission to the intensive care unit, severity, and in-hospital mortality. The annual incidence of hospitalizations because of FIA per 100,000 person-years was estimated and analyzed using Poisson regression models. Multivariable logistic regression models were constructed to identify which variables were associated with severe FIA. RESULTS A total of 2161 hospital admissions for FIA were recorded in Spain from 2016 to 2021. The overall incidence rate was 0.77 cases per 100,000 person-years. The highest incidence was found in those aged <15 years (3.68), with lower figures among those aged 15 to 59 years (0.25) and ≥60 years (0.29). Poisson regression showed a significant increase in incidence from 2016 to 2021 only among children (3.78 per 100,000 person-years vs 5.02 per 100,000 person-years; P=.04). The most frequent food triggers were "milk and dairy products" (419/2161, 19.39% of cases) and "peanuts or tree nuts and seeds" (409/2161, 18.93%). Of the 2161 patients, 256 (11.85%) were hospitalized because FIA required admission to the intensive care unit, and 11 (0.51%) patients died in the hospital. Among children, the most severe cases of FIA appeared in patients aged 0 to 4 years (40/99, 40%). Among adults, 69.4% (111/160) of cases occurred in those aged 15 to 59 years. Multivariable logistic regression showed the variables associated with severe FIA to be age 15 to 59 years (odds ratio 5.1, 95% CI 3.11-8.36), age ≥60 years (odds ratio 3.87, 95% CI 1.99-7.53), and asthma (odds ratio 1.71,95% CI 1.12-2.58). CONCLUSIONS In Spain, the incidence of hospitalization because of FIA increased slightly, although the only significant increase (P=.04) was among children. Even if in-hospital mortality remains low and stable, the proportion of severe cases is high and has not improved from 2016 to 2021, with older age and asthma being risk factors for severity. Surveillance must be improved, and preventive strategies must be implemented to reduce the burden of FIA.
Collapse
Affiliation(s)
- Rodrigo Jimenez-Garcia
- Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Ana Lopez-de-Andres
- Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Valentin Hernandez-Barrera
- Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorcon, Spain
| | - Jose J Zamorano-Leon
- Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Natividad Cuadrado-Corrales
- Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Javier de Miguel-Diez
- Respiratory Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Jose L Del-Barrio
- Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorcon, Spain
| | | | - David Carabantes-Alarcon
- Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| |
Collapse
|
8
|
Wong GWK. Food allergies around the world. Front Nutr 2024; 11:1373110. [PMID: 38938666 PMCID: PMC11208673 DOI: 10.3389/fnut.2024.1373110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Accepted: 04/03/2024] [Indexed: 06/29/2024] Open
Abstract
The increase in the prevalence of food allergy has been considered as the second wave in the allergy epidemic following the first wave of increase in asthma and allergic rhinitis. It is well known that the prevalence of allergic conditions would follow economic development and urbanization in many countries or regions. In developed countries, one in three children suffered from at least one allergic disorder and these conditions include food allergy, eczema, allergic rhinitis and asthma. Food allergy is very often the first allergic manifestation affecting infants and young children. The exact etiologies are not known. The clinical manifestations ranged from a simple rash or an itch around the mouth, to the more severe manifestations of angioedema and potentially fatal anaphylaxis. Among all cases of childhood anaphylaxis, food is the most common cause. The common allergens resulting in food allergies in developed countries include egg, milk, fish, wheat, peanuts and tree nuts. However, there are marked variations in the patterns of food allergens in developing countries. In line with the epidemiology of asthma, food allergy is also much less common in rural areas. Clear understanding of reasons explaining the disparity of food allergies between urban and rural population would pave the way to the development of effective primary prevention for food allergy.
Collapse
Affiliation(s)
- Gary Wing-Kin Wong
- Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
| |
Collapse
|
9
|
Dölle-Bierke S, Worm M. Reply to "Correct nomenclature of wheat allergy dependent on augmentation factors". THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE 2023; 11:3563-3564. [PMID: 37945214 DOI: 10.1016/j.jaip.2023.08.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Accepted: 08/16/2023] [Indexed: 11/12/2023]
Affiliation(s)
- Sabine Dölle-Bierke
- Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Margitta Worm
- Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
| |
Collapse
|
10
|
Abrams EM, Protudjer JLP. Factoring in cofactors in the diagnosis and management of anaphylaxis. Ann Allergy Asthma Immunol 2023; 130:695-696. [PMID: 37270227 DOI: 10.1016/j.anai.2023.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Revised: 04/11/2023] [Accepted: 04/13/2023] [Indexed: 06/05/2023]
Affiliation(s)
- Elissa M Abrams
- Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada; Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
| | - Jennifer L P Protudjer
- Rady Faculty of Health Sciences, Department of Pediatrics and Child Health, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada; Faculty of Agricultural and Food Sciences, Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; George and Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba, Canada; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|